www.fdanews.com/articles/85230-abbott-receives-fda-510k-clearance-to-market-freestyle-freedom-blood-glucose-monitoring-system
ABBOTT RECEIVES FDA 510K CLEARANCE TO MARKET FREESTYLE FREEDOM BLOOD GLUCOSE MONITORING SYSTEM
March 13, 2006
Abbott Diabetes Care announced
today it has received 510(k) clearance from the U.S. Food and Drug Administration
to market its FreeStyle Freedom blood glucose monitoring system for consumer use.
PR
Newswire